BRCA2 and cancer: Therefore, cancer cells lacking functional BRCA2 are vulnerable to drugs that induce double-stranded DNA breaks, e.g., mitomycin-C, cisplatinum, and poly ADP-ribose polymerase inhibitor23, 24.